Department of Cardiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.
BMC Cardiovasc Disord. 2019 Nov 10;19(1):252. doi: 10.1186/s12872-019-1239-4.
To assess the value of D-dimer and its combination with The Global Registry of Acute Coronary Events (GRACE) score in predicting in-hospital mortality in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI).
In 5923 ACS patients undergoing PCI, the role of D-dimer and the added value of D-dimer to GRACE score for predicting in-hospital mortality were tested.
After multivariable adjustment, D-dimer could significantly predict in-hospital mortality. Also, it could significantly improve the prognostic performance of GRACE score (C-statistic: z = 2.269, p = 0.023; IDI: 0.016, p = 0.032; NRI: 0.291, p = 0.035).
In patients with ACS undergoing PCI, D-dimer was an independent predictor of in-hospital death. It could also improve the prognostic performance of GRACE score.
评估 D-二聚体及其与全球急性冠状动脉事件注册(GRACE)评分联合用于预测行经皮冠状动脉介入治疗(PCI)的急性冠状动脉综合征(ACS)患者住院死亡率的价值。
在 5923 例行 PCI 的 ACS 患者中,测试 D-二聚体的作用以及 D-二聚体对 GRACE 评分预测住院死亡率的附加价值。
经多变量调整后,D-二聚体可显著预测住院死亡率。此外,它还可显著改善 GRACE 评分的预后性能(C 统计量:z=2.269,p=0.023;IDI:0.016,p=0.032;NRI:0.291,p=0.035)。
在接受 PCI 的 ACS 患者中,D-二聚体是住院死亡的独立预测因子。它还可以改善 GRACE 评分的预后性能。